Results

Total Results: 726 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

241. Screening for Cognitive Impairment in Older Adults: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nKXBrHEeNwh37DFKTXapt8
     March 18, 2014 - Other reported risk factors for cognitive impairment include cardiovascular risk factors (such as diabetes … Treatment Pharmacologic treatments approved by the U.S.

242. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-children-adolescents-screening
     August 19, 2021 - What are the harms of treatment of FH or multifactorial dyslipidemia in children and adolescents? … What is the optimal timing of statin treatment initiation for FH? … initiation KQs 4, 5 (Treatment benefits and harms): Treatment studies can have populations identified … benefits and harms): No treatment or usual care   Outcomes KQs 1, 4 (Screening and treatment … idiopathic hypercalcemia, Klinefelter syndrome, Werner syndrome, polycystic ovary syndrome, type 1 or 2 diabetes

243. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-in-children-screening
     August 19, 2021 - What are the harms of treatment of FH or multifactorial dyslipidemia in children and adolescents? … What is the optimal timing of statin treatment initiation for FH? … initiation KQs 4, 5 (Treatment benefits and harms): Treatment studies can have populations identified … benefits and harms): No treatment or usual care   Outcomes KQs 1, 4 (Screening and treatment … idiopathic hypercalcemia, Klinefelter syndrome, Werner syndrome, polycystic ovary syndrome, type 1 or 2 diabetes

244. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/v7w4xaGG822hVc_SCU3tQ_
     November 01, 2022 - are limited to the treatment of menopausal symptoms and the prevention of post- menopausal osteoporosis … for the treatment of menopausal symptoms (eg, vasomotor hot flashes or vulvovaginal symptoms) or for … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … Two trials reported on the effects of menopausal hormone therapy on incident diabetes. … • The comparative benefits and harms of different formulations and treatment durations of menopausal

245. A and B Recommendations | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations
     December 01, 2021 - Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment … Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment … USPSTF recommends that clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy … information about identification of persons at high risk and selection of effective antiretroviral therapy … Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate

246. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
     May 29, 2012 - Food and Drug Administration include short-term treatment of menopausal symptoms, such as vasomotor hot … for elevated cholesterol levels, hypertension, and diabetes. … Estrogen and estrogen with progestin therapies for postmenopausal women. Silver Spring, MD: U.S. … Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results … Effects of combination estrogen plus progestin hormone treatment on cognition and affect.

247. Recommendation: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - Treatments and Interventions Asymptomatic adults at increased risk for CVD are usually treated with … Two RCTs (total N = 4626) compared using the ABI to guide decisions to start aspirin therapy vs usual … the effect of screening with CAC score on risk perception, adherence to medication, and behavioral therapies … Some comments also expressed belief that CAC score testing leads to better adherence to preventive therapies … Group; Diabetes Registry Group; Royal College of Physicians Edinburgh.

248. Recommendation: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening
     February 02, 2021 - carotid artery stenosis, including older age, male sex, hypertension, smoking, hypercholesterolemia, diabetes … Treatment Medical and surgical options are available for treatment of carotid artery stenosis. … disease and often includes statins, antiplatelet medications, management of hypertension and diabetes … These studies included participants with cardiovascular disease risk factors such as diabetes, hypertension … conducted during the 1990s. 8 Many study participants had hypertension, coronary artery disease, or diabetes

249. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
     January 01, 2002 - Placebo Placebo Placebo No placebo Additional None β-Carotene Warfarinb Felodipine with Vitamin E therapies … treatment and control groups. … In PHS, patients with diabetes derived greater benefit from aspirin than those without diabetes (RR, … Aspirin effects on mortality and morbidity in patients with diabetes mellitus. … Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from

250. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
     January 15, 2002 - The proportion of patients with diabetes mellitus was small in each trial (PPP, 17 percent; HOT, 8 percent … In PHS, patients with diabetes derived greater benefit from aspirin than those without diabetes (RR, … Aspirin effects on mortality and morbidity in patients with diabetes mellitus. … Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from … Control No placebo Placebo Placebo Placebo No placebo Additional therapies

251. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
     September 18, 2018 - level version of EQ-5D; EQ-VAS, EuroQol Visual Analogue Scale; FACT-G, Functional Assessment of Cancer Therapy—General … Orlistat in the long-term treatment of obesity in primary care settings. … Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification … intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention … Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial.

252. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_nVeFxDCT9L-_cnDf_V3fK
     July 17, 2018 - Given that risk estimates are used to guide preventive therapy such as as- pirin and statins,6,8-10 improved … and appraise updated evidence on the benefits and harms of nontraditional risk factor assessment and therapy … for each KQ or method- ological and clinical heterogeneity, including differences in out- comes and treatments … initiate preventive therapies have been lowered to 7.5% or 10%, and reported NRI will capture movement … In the absence of this evidence, studies in which preventive therapies were guided by nontraditional

253. Draft Research Plan: Menopausal Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-women-primary-prevention-chronic-conditions
     February 18, 2021 - in progress Draft Research Plan Menopausal Hormone Therapy in Postmenopausal Women: Primary … What is the average treatment duration in women who start HT for menopausal symptoms? … Localized (nonsystemic) treatments such as rings or gels, contraceptives, other hormones, or treatments … of menopausal symptoms such as over-the-counter preparations or compounded bioidentical therapies that … life (if related to chronic conditions of interest) Functional capacity Urinary incontinence Diabetes

254. Draft Research Plan: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
     February 18, 2021 - in progress Draft Research Plan Hormone Therapy for the Primary Prevention of Chronic Conditions … What is the average treatment duration in women who start HT for menopausal symptoms? … Localized (nonsystemic) treatments such as rings or gels, contraceptives, other hormones, or treatments … of menopausal symptoms such as over-the-counter preparations or compounded bioidentical therapies that … life (if related to chronic conditions of interest) Functional capacity Urinary incontinence Diabetes

255. Archived: Asymptomatic Bacteriuria in Adults: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-adults-screening-2004
     January 01, 2004 - Results from a study of women with diabetes who were treated for asymptomatic bacteriuria demonstrated … complications. 1 Although there were short-term results in clearing bacteriuria with antimicrobial therapy … Antimicrobial treatment in diabetic women with asymptomatic bacteriuria.

256. Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z6Rfj-qwfoMbuLp-hBmhzS
     May 01, 2021 - Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive … Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive … Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure … Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. … The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes.

257. Screening for Lipid Disorders in Children: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BwAo_shwmJLSRguyWxaXpP
     July 01, 2007 - • Children and adolescents with diabetes may be at especially high risk for dyslipidemia and cardiovascular … Screening children and adolescents with diabetes for dyslipidemia has been recommended by other groups … Secondary causes of dyslipidemia include diabetes, nephrotic syndrome, and hypothyroidism.2 The USPSTF … Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial … Garlic extract therapy in children with hypercholesterolemia.

258. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
     October 01, 2009 - diabetes will fall into the intermediate-risk category. … Some con- sider diabetes as a CHD equivalent and others use it as a risk factor for CHD. … would be restratified into high- risk groups, the benefit of aggressive medical management or other treatments … The benefits of such therapy based on this strat- egy remain uncertain. … Diabetes Care. 2002;25:1845-50. [PMID: 12351489] 12.

259. Draft Recommendation: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/chronic-obstructive-pulmonary-disease-screening1
     November 02, 2021 - to stop smoking. 12 Pharmacologic (e.g., bronchodilators and anti-inflammatory therapies) and nonpharmacologic … therapies (e.g., interventions addressing self-management of disease, diet, exercise, and immunizations … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … A second study found that ICS may increase the risk of developing diabetes (n=9,923 for diabetes onset

260. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6cRgd5whkAvSGESSQsrQLR
     January 01, 2020 - Treatments and Interventions Asymptomatic adults at increased risk for CVD are usually treated with … Two RCTs (total N = 4626) compared using the ABI to guide decisions to start aspirin therapy vs usual … the effect of screening with CAC score on risk perception, adherence to medication, and behav- ioral therapies … Some comments also expressed belief that CAC score testing leads to better adherence to preven- tive therapies … Group; Diabetes Registry Group; Royal College of Physicians Edinburgh.